[Current status, limitations and prospects in clinical trials of cancer gene therapy].
Wang
Fu-sheng
FS
D000256:Adenoviridae / Q000235:genetics; D016158:Genes, p53; D015316:Genetic Therapy / Q000009:adverse effects / Q000379:methods; D005822:Genetic Vectors; D006801:Humans; D009369:Neoplasms / Q000628:therapy*